JNJ-77242113, Film-Coated Tablet without JNJ-77242113, Film-Coated Tablet without Deucravacitinib, DEUCRAVACITINIB
77242113PSO3004
Phase 3 small_molecule active
Quick answer
JNJ-77242113, Film-Coated Tablet without JNJ-77242113, Film-Coated Tablet without Deucravacitinib, DEUCRAVACITINIB for Moderate to Severe Plaque Psoriasis is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Moderate to Severe Plaque Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active